CH451945A - Verfahren zur Herstellung von neuen N-Pyrimidylanthranilsäuren - Google Patents

Verfahren zur Herstellung von neuen N-Pyrimidylanthranilsäuren

Info

Publication number
CH451945A
CH451945A CH1616164A CH1616164A CH451945A CH 451945 A CH451945 A CH 451945A CH 1616164 A CH1616164 A CH 1616164A CH 1616164 A CH1616164 A CH 1616164A CH 451945 A CH451945 A CH 451945A
Authority
CH
Switzerland
Prior art keywords
pyrimidylanthranilic
acids
preparation
new
pyrimidylanthranilic acids
Prior art date
Application number
CH1616164A
Other languages
German (de)
English (en)
Inventor
Max Dr Matter
Rudolf Dr Staehelin Fritz
Original Assignee
Haco Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NL129020D priority Critical patent/NL129020C/xx
Application filed by Haco Ag filed Critical Haco Ag
Priority to CH1616164A priority patent/CH451945A/de
Priority to US513597A priority patent/US3361749A/en
Priority to ES0320729A priority patent/ES320729A1/es
Priority to NO160909A priority patent/NO117424B/no
Priority to IL24797A priority patent/IL24797A/en
Priority to DE19651545978 priority patent/DE1545978A1/de
Priority to FI653001A priority patent/FI45048C/fi
Priority to AT1123965A priority patent/AT256854B/de
Priority to BE673707D priority patent/BE673707A/xx
Priority to NL6516326A priority patent/NL6516326A/xx
Priority to DK643865AA priority patent/DK117835B/da
Priority to BR175691/65A priority patent/BR6575691D0/pt
Priority to FR42331A priority patent/FR5213M/fr
Priority to FR42328A priority patent/FR1469035A/fr
Priority to GB53540/65A priority patent/GB1132244A/en
Publication of CH451945A publication Critical patent/CH451945A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Laminated Bodies (AREA)
  • Shaping By String And By Release Of Stress In Plastics And The Like (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CH1616164A 1964-12-15 1964-12-15 Verfahren zur Herstellung von neuen N-Pyrimidylanthranilsäuren CH451945A (de)

Priority Applications (16)

Application Number Priority Date Filing Date Title
NL129020D NL129020C (enExample) 1964-12-15
CH1616164A CH451945A (de) 1964-12-15 1964-12-15 Verfahren zur Herstellung von neuen N-Pyrimidylanthranilsäuren
US513597A US3361749A (en) 1964-12-15 1965-12-13 Certain n-pyrimidyl anthranilic acid derivatives
FI653001A FI45048C (fi) 1964-12-15 1965-12-14 Menetelmä analgeettisesti ja/tai tulehduksenvastaisesti vaikuttavien a ntraniilihappojohdannaisten valmistamiseksi.
NO160909A NO117424B (enExample) 1964-12-15 1965-12-14
IL24797A IL24797A (en) 1964-12-15 1965-12-14 N-pyrimidyl anthranilic acid derivatives and a method for the production thereof
DE19651545978 DE1545978A1 (de) 1964-12-15 1965-12-14 N-(4-Pyrimidinyl)-anthranilsaeuren und deren Derivate,sowie Verfahren zur Herstellung derselben
ES0320729A ES320729A1 (es) 1964-12-15 1965-12-14 Procedimiento para la sintesis de nuevos derivados de acido antranilico.
AT1123965A AT256854B (de) 1964-12-15 1965-12-14 Verfahren zur Herstellung von neuen Anthranilsäurederivaten
BE673707D BE673707A (enExample) 1964-12-15 1965-12-14
NL6516326A NL6516326A (enExample) 1964-12-15 1965-12-15
DK643865AA DK117835B (da) 1964-12-15 1965-12-15 Fremgangsmåde til fremstilling af terapeutisk virksomme N-4-pyrimidinyl-anthranilsyreforbindelser eller salte deraf.
BR175691/65A BR6575691D0 (pt) 1964-12-15 1965-12-15 Processo para a preparacao de novos derivados do acido antranilico
FR42331A FR5213M (enExample) 1964-12-15 1965-12-15
FR42328A FR1469035A (fr) 1964-12-15 1965-12-15 Nouveaux dérivés de l'acide anthranilique et procédé pour leur préparation
GB53540/65A GB1132244A (en) 1964-12-15 1965-12-16 New n-pyrimidinyl anthranilic acid derivatives and a method for the production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1616164A CH451945A (de) 1964-12-15 1964-12-15 Verfahren zur Herstellung von neuen N-Pyrimidylanthranilsäuren

Publications (1)

Publication Number Publication Date
CH451945A true CH451945A (de) 1968-05-15

Family

ID=4414930

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1616164A CH451945A (de) 1964-12-15 1964-12-15 Verfahren zur Herstellung von neuen N-Pyrimidylanthranilsäuren

Country Status (14)

Country Link
US (1) US3361749A (enExample)
AT (1) AT256854B (enExample)
BE (1) BE673707A (enExample)
BR (1) BR6575691D0 (enExample)
CH (1) CH451945A (enExample)
DE (1) DE1545978A1 (enExample)
DK (1) DK117835B (enExample)
ES (1) ES320729A1 (enExample)
FI (1) FI45048C (enExample)
FR (2) FR5213M (enExample)
GB (1) GB1132244A (enExample)
IL (1) IL24797A (enExample)
NL (2) NL6516326A (enExample)
NO (1) NO117424B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH448083A (de) * 1963-05-04 1967-12-15 Ciba Geigy Verwendung von neuen Hydroxyaryl-pyrimidinen bei Verfahren zum Schützen von nicht-textilen organischen Materialien
CA2406562C (en) * 2000-05-08 2009-09-15 Janssen Pharmaceutica N.V. Hiv replication inhibiting pyrimidines and triazines
GB0206215D0 (en) * 2002-03-15 2002-05-01 Novartis Ag Organic compounds
GB0305929D0 (en) * 2003-03-14 2003-04-23 Novartis Ag Organic compounds
PT2287156E (pt) 2003-08-15 2013-08-26 Novartis Ag 2,4-di(fenilamino)-pirimidinas úteis no tratamento de doenças neoplásicas, desordens inflamatórias e do sistema imunitário
ATE517874T1 (de) * 2005-10-21 2011-08-15 Exelixis Inc Pyrimidinone als modulatoren von caseinkinase ii (ck2)
GEP20125691B (en) 2006-12-08 2012-11-26 Irm Llc Compounds and compositions as protein kinase inhibitors
LU92852B1 (en) * 2015-10-20 2017-05-02 Athanasios Spathis NURR1:RXR activating compounds for simultaneous treatment of symptoms and pathology of Parkinsons disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971307A (en) * 1961-03-02 1964-09-30 Wellcome Found 5-anilinopyrimidines

Also Published As

Publication number Publication date
BR6575691D0 (pt) 1973-09-06
FI45048C (fi) 1972-03-10
FR1469035A (fr) 1967-02-10
US3361749A (en) 1968-01-02
DK117835B (da) 1970-06-08
DE1545978A1 (de) 1969-12-11
ES320729A1 (es) 1966-05-16
BE673707A (enExample) 1966-04-01
GB1132244A (en) 1968-10-30
NO117424B (enExample) 1969-08-11
FI45048B (enExample) 1971-11-30
IL24797A (en) 1969-11-12
FR5213M (enExample) 1967-07-03
NL129020C (enExample)
NL6516326A (enExample) 1966-06-16
AT256854B (de) 1967-09-11

Similar Documents

Publication Publication Date Title
CH484031A (de) Verfahren zur Herstellung von d-Phenylessigsäuren
AT257618B (de) Verfahren zur Herstellung von neuen N-Phenylpiperazinen
CH451139A (de) Verfahren zur Herstellung von neuen Indenopyridin-Derivaten
CH451945A (de) Verfahren zur Herstellung von neuen N-Pyrimidylanthranilsäuren
CH466298A (de) Verfahren zur Herstellung von neuen Isochinolobenzodiazepin-Derivaten
AT246133B (de) Verfahren zur Herstellung von neuen 4-Nitropyrazolen
AT254173B (de) Verfahren zur Herstellung von neuen p-Acylaminophenyl-acylsalicylaten
CH490382A (de) Verfahren zur Herstellung von 2-Phenylalkylindolylsäuren
AT252235B (de) Verfahren zur Herstellung von neuen Hydrazino-2-thiazolinen
AT252224B (de) Verfahren zur Herstellung von neuen 2-Aminobenzoyloxy-naphthohydrochinonen
CH479520A (de) Verfahren zur Herstellung von a-Oxycarbonsäuren
AT270675B (de) Verfahren zur Herstellung von neuen Polyfluoralkylphosphorverbindungen
AT251766B (de) Verfahren zur Herstellung von neuen 1-Methyl-d-lysergsäureamiden
AT260899B (de) Verfahren zur Herstellung von neuen Sulfamylanthranilsäureamiden
CH453358A (de) Verfahren zur Herstellung von neuen N-Alkenyl-piperidinen
CH464959A (de) Verfahren zur Herstellung von neuen substituierten Phenyl-a-aminoketonen
AT256078B (de) Verfahren zur Herstellung von neuen substituierten Benzoesäuren
AT262988B (de) Verfahren zur Herstellung von neuen Derivaten des 3-Phenylpyrrols
AT250336B (de) Verfahren zur Herstellung von 2, 5-Diarylaminoterephthalsäuren
AT252209B (de) Verfahren zur Herstellung von Sulfamylanthranilsäuren
CH479581A (de) Verfahren zur Herstellung von 4-Propylhygrinsäuren
AT252905B (de) Verfahren zur Herstellung von neuen 4-Halogen-5-alkoxysulfamyl-anthranilsäuren
AT246127B (de) Verfahren zur Herstellung von neuen N-Acylamido-5-nitro-2-furamidinen
CH470337A (de) Verfahren zur Herstellung von neuen (2-Methylenalkanoyl)-benzoesäuren
AT251573B (de) Verfahren zur Herstellung von neuen Thieno-benzothiazin-Derivaten